National University Corporation Hokkaido University;Fuso Pharmaceutical Industries, Ltd.
发明人:
申请号：
EP18836127.3
公开号：
EP3656400A1
申请日:
2018.07.19
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present invention provides a novel therapeutic strategy using an inhibitor targeting PD-1/PD-L1. A pharmaceutical composition which comprises a COX-2 inhibitor and is administered before, after or simultaneously with the administration of an inhibitor targeting PD-1/PD-L1. A potentiator for the immunostimulatory effect of an inhibitor targeting PD-1/PD-L1, which comprises a COX-2 inhibitor.
